UCP2 and Hypercholesterolemia: MΦ3 (Abca1high) that highly expresses the efferocytosis markers (Abca1, Axl, Cd36, and Ucp2)55,56 is predominant in early atherogenic phase at 2 weeks post-PCL under hypercholesterolemia.